Amgen invests $300M

Amgen to invest additional $300 million to boost US manufacturing footprint

Amgen announced a $300 million investment to expand its Puerto Rico biologics manufacturing facility amid potential U.S. tariffs on imported medicines. This expands prior commitments totaling over $1.